Lexicon Pharmaceuticals Inc (LXRX)

Lexicon Pharmaceuticals Inc (LXRX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $783M; returns 1 day -4.7%, 1 week -6.6%, 1 year +1.4%.

Lexicon Pharmaceuticals Inc. (LXRX) is a biopharmaceutical company focused on discovering, developing, and commercializing pharmaceutical products. Lexicon utilizes its Genome5000™ program to identify and validate drug targets. The company focuses on therapies for cardiometabolic diseases and neuropathic pain.

Groups LXRX belongs to

• Biotechnology
• Biopharmaceutical
• Metabolic Disorders
• Type 1 Diabetes
• Cardiovascular Therapies
• Clinical Stage Biopharma
• Pharmaceuticals
• Commercial Stage Biotech
• Life Sciences

LXRX financial model: income statement, cash flow and balance sheet